Navigation Links
Antibiotics Procurement Research Report Now Available from IBISWorld
Date:10/27/2013

Los Angeles, CA (PRWEB) October 27, 2013

Antibiotic products have a buyer power score of 3.3 out of 5.0. A high score indicates a competitive advantage for the buyers. The score reflects current negative pricing trends and moderate rate of bargain power, but is positively influenced by the ease of purchasing complexity and strong purchasing confidence. According to IBISWorld procurement analyst Anna Son, “prices for antibiotics have fluctuated over the past three years as a result of rising regulatory compliance costs and generics competition”. Due to the patent expiry of many blockbuster drugs, increased availability of generic antibiotics, which are generally far less expensive than their brand-name counterparts, has driven down the average price of these products. Nonetheless, a limited number of suppliers of antibiotics that treat rare diseases have kept prices high.

The cost associated with switching suppliers of antibiotics varies depending on the type of supplier. “For example, buyers can expect lower costs associated with switching suppliers of commonly used antibiotics, such as amoxicillin, because of their instant availability and low buying lead time”, says Son. This provides buyers with the opportunity to restock their inventory in a relatively short time frame, barring contract negotiations. In this case, buyers have greater leverage in negotiating contracts. On the contrary, buyers are more likely to incur higher costs when they switch suppliers of antibiotics that treat rare disease, especially when there are only a small number of suppliers of that particular drug. As such, suppliers of rare antibiotics have greater negotiating power over buyers.

Furthermore, antibiotics manufacturers typically capture high profit margins. High margins usually give buyers room to negotiate for lower prices. However, the low availability of substitutes, a moderate level of market share concentration and the high specialization among suppliers limit the buyers' negotiating power. In addition, the antibiotics market is mature and has a low level of financial risk given its established place in the supply chain. The three largest companies in the industry are AstraZeneca, Cubist Pharmaceuticals and GlaxoSmithKline.

For more information, visit IBISWorld’s Antibiotics procurement research report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Procurement Report Key Topics

This report is intended to help buyers of antibiotic products. Antibiotics, also known as antibacterials, are types of medications that destroy or slow the growth of microorganisms such as bacteria, fungi and parasites. Most antibiotics have two names, the brand name, created by the original drug manufacturer, and a generic name, which is based on the antibiotic's chemical structure. Suppliers of antibiotics include manufacturers, wholesalers and retailers. This report excludes antibiotic products for veterinary use.

Executive Summary
Pricing Environment
Price Fundamentals
Benchmark Price
Pricing Model
Price Drivers
Recent Price Trend
Price Forecast
Product Characteristics
Product Life Cycle
Total Cost of Ownership
Product Specialization
Substitute Goods
Regulation
Quality Control
Supply Chain & Vendors
Supply Chain Dynamics
Supply Chain Risk
Imports
Competitive Environment
Market Share Concentration
Vendor Financial Benchmarks
Switching Costs
Purchasing Process
Buying Basics
Buying Lead Time
Selection Process
Key RFP Elements
Negotiation Questions
Buyer Power Factors
Key Statistics

About IBISWorld Inc.
IBISWorld is one of the world's leading publishers of business intelligence, specializing in Industry research and Procurement research. Since 1971, IBISWorld has provided thoroughly researched, accurate and current business information. With an extensive online portfolio, valued for its depth and scope, IBISWorld’s procurement research reports equip clients with the insight necessary to make better purchasing decisions, faster. Headquartered in Los Angeles, IBISWorld Procurement serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11262862.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Antibiotics Linked to Retinal Detachment Risk
2. Researchers find evidence of banned antibiotics in poultry products
3. Study Finds Antibiotics Best for Appendicitis
4. FDA Seeks to Limit Antibiotics in Animal Feed
5. Timing of antibiotics important in reducing infections after C-section
6. Two Antibiotics Linked to Liver Injury in Elderly
7. Antibiotics Dont Ease Coughs in Kids With Common Cold: Study
8. Electronic visits offer accurate diagnoses, may lead to overprescribing of antibiotics
9. BioMAP screening procedure could streamline search for new antibiotics
10. Frog-in-bucket-of-milk folklore leads to potential new antibiotics
11. Evidence insufficient to recommend routine antibiotics for joint replacement patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... Brenntag Specialties, Inc.(BSI) , is pleased ... Beverage and Dietary Supplement market segments across the western United ... east of the Rocky Mountains since 2012. Consistent performance in business development ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a man ... , was determined to find solutions to his problems – and he did. Now Nabat, ... is ready to introduce his breakthrough inventions to the world and better people's lives. His ...
(Date:2/8/2016)... Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... and surrounding areas with a vital new community enrichment program, has teamed up with ... local women and children suffering from intimate abuse. To support all those victimized by ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... executive networking and relationship-marketing firm, announced today that nominations will be accepted ... Executive® (ISE®) West Awards. , Awards include the Information Security Executive® ...
(Date:2/8/2016)... ... ... the Rocky Mountain region’s longest running and impressive garden and home show where you ... the most incredible gardens and home improvement experts that attend this amazing show. ... 700 14th St. Denver CO, is an exciting event that Performance Mobility has enjoyed ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today ... U.S. Food and Drug Administration (FDA) on February 4, ... hold on the clinical studies being conducted under the ... clinical hold impacts part of the clinical work currently ... planned clinical trials. --> ...
(Date:2/5/2016)... IRVINE, Calif. , Feb. 5, 2016 /PRNewswire/ ... leading global aesthetic device company, announced today that ... Syneron Candela North America, is scheduled to participate ... Global Healthcare Conference on February 11, 2016 in ... conference will allow institutional investors to meet with ...
(Date:2/5/2016)... http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> http://www.researchandmarkets.com/research/jsc97m/global ) ... "Global Musculoskeletal Partnering 2010-2016: Deal trends, players ... offering. --> Research and ...
Breaking Medicine Technology: